• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾盂和输尿管肿瘤在肌层浸润性上尿路上皮癌中的比较。

Comparison between renal pelvic and ureteral tumors in muscle-invasive upper tract urothelial carcinoma.

机构信息

Department of Urology, First Affiliated Hospital, Dalian Medical University, Dalian, China.

Department of Pathology and Laboratory Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA.

出版信息

Cancer Sci. 2023 Mar;114(3):984-994. doi: 10.1111/cas.15634. Epub 2022 Nov 30.

DOI:10.1111/cas.15634
PMID:36330561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9986090/
Abstract

Although renal pelvic and ureteral urothelial carcinoma share similarities in their origins, disparities on a genetic and clinical level make them divergent entities. Clinical information from the Surveillance, Epidemiology, and End Results (SEER) database was used to validate the characteristics and molecular subtypes using single-center data, which were compared between the two types of muscle-invasive tumors. Simultaneously, to expand the sample size for further verification, we explored a deep learning algorithm to correctly classify molecular subtypes from H&E histology slides. We suggested that the renal pelvic group might have a proclivity towards luminal and the ureter towards basal and P53-like. Furthermore, we explore the heterogeneity of matrix and immune tumor microenvironment, and the ureteral group had more immune cell infiltration and higher stiffness. Collectively, these results showed that muscle-invasive upper tract urothelial carcinoma exist in distinct properties of clinical characteristics, molecular subtype, and tumor microenvironment.

摘要

虽然肾盂和输尿管尿路上皮癌在起源上有相似之处,但在遗传和临床水平上的差异使它们成为不同的实体。我们利用监测、流行病学和最终结果(SEER)数据库中的临床信息,使用单中心数据对特征和分子亚型进行验证,并对两种肌层浸润性肿瘤进行比较。同时,为了进一步验证,我们探索了一种深度学习算法,以正确地从 H&E 组织学切片中分类分子亚型。我们提出,肾盂组可能倾向于腔型,而输尿管组倾向于基底型和 P53 样型。此外,我们还探索了基质和免疫肿瘤微环境的异质性,输尿管组有更多的免疫细胞浸润和更高的硬度。综上所述,这些结果表明,肌层浸润性上尿路上皮癌在临床特征、分子亚型和肿瘤微环境方面存在明显的特性差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/900e5cd5d002/CAS-114-984-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/91ff868d4595/CAS-114-984-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/2530744abe51/CAS-114-984-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/4dd9f393ce29/CAS-114-984-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/c68eff816ea8/CAS-114-984-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/9e48402dfc91/CAS-114-984-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/900e5cd5d002/CAS-114-984-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/91ff868d4595/CAS-114-984-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/2530744abe51/CAS-114-984-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/4dd9f393ce29/CAS-114-984-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/c68eff816ea8/CAS-114-984-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/9e48402dfc91/CAS-114-984-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d2/9986090/900e5cd5d002/CAS-114-984-g002.jpg

相似文献

1
Comparison between renal pelvic and ureteral tumors in muscle-invasive upper tract urothelial carcinoma.肾盂和输尿管肿瘤在肌层浸润性上尿路上皮癌中的比较。
Cancer Sci. 2023 Mar;114(3):984-994. doi: 10.1111/cas.15634. Epub 2022 Nov 30.
2
Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.上尿路尿路上皮癌的淋巴结转移模式及建议的清扫模板
J Urol. 2015 Dec;194(6):1567-74. doi: 10.1016/j.juro.2015.06.077. Epub 2015 Jun 19.
3
[Simultaneous bilateral renal pelvic tumors: a case report].[双侧肾盂肿瘤同时发生:一例报告]
Hinyokika Kiyo. 1991 Dec;37(12):1703-5.
4
Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌的全面基因组特征分析。
Eur Urol. 2017 Oct;72(4):641-649. doi: 10.1016/j.eururo.2017.05.048. Epub 2017 Jun 7.
5
Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data.肾盂、输尿管和膀胱癌的癌具有致癌灶,这在肿瘤登记数据的流行病学分析中得到揭示。
Clin Genitourin Cancer. 2019 Dec;17(6):436-442. doi: 10.1016/j.clgc.2019.07.011. Epub 2019 Jul 19.
6
Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.上尿路尿路上皮癌对非肌肉浸润性膀胱癌患者对卡介苗反应的影响。
BJU Int. 2021 Nov;128(5):568-574. doi: 10.1111/bju.15344. Epub 2021 Feb 15.
7
[Synchronous tumors in right renal pelvis and left ureter].[右肾盂和左输尿管的同步肿瘤]
Hinyokika Kiyo. 1985 Apr;31(4):655-63.
8
Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的危险因素:一项荟萃分析。
Urol Oncol. 2014 Oct;32(7):989-1002. doi: 10.1016/j.urolonc.2014.01.022. Epub 2014 Jul 28.
9
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.上尿路尿路上皮癌临床病理特征的预测中,上尿路细胞学和活检的临床实用性和一致性。
Hum Pathol. 2019 Apr;86:76-84. doi: 10.1016/j.humpath.2018.11.021. Epub 2018 Dec 8.
10
A Pilot Study of In Vivo Confocal Laser Endomicroscopy of Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌的体内共聚焦激光内镜检查的初步研究。
J Endourol. 2015 Dec;29(12):1418-23. doi: 10.1089/end.2015.0523. Epub 2015 Oct 6.

引用本文的文献

1
Management of Upper Tract Urothelial Carcinoma in a Double Collecting System Kidney.双集合系统肾脏中上尿路尿路上皮癌的管理
J Pers Med. 2024 Jan 30;14(2):158. doi: 10.3390/jpm14020158.

本文引用的文献

1
Molecular classification and diagnostics of upper urinary tract urothelial carcinoma.上尿路尿路上皮癌的分子分类和诊断。
Cancer Cell. 2021 Jun 14;39(6):793-809.e8. doi: 10.1016/j.ccell.2021.05.008.
2
Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.上尿路尿路上皮癌行内镜下保留肾单位手术的术前风险分层:一项国际协作研究。
Eur Urol. 2021 Oct;80(4):507-515. doi: 10.1016/j.eururo.2021.05.004. Epub 2021 May 20.
3
Residual cyclegan for robust domain transformation of histopathological tissue slides.
用于组织病理学切片稳健域变换的剩余循环生成对抗网络。
Med Image Anal. 2021 May;70:102004. doi: 10.1016/j.media.2021.102004. Epub 2021 Feb 18.
4
The matrix in cancer.癌症中的基质。
Nat Rev Cancer. 2021 Apr;21(4):217-238. doi: 10.1038/s41568-020-00329-7. Epub 2021 Feb 15.
5
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.新辅助 PD-L1 联合 CTLA-4 阻断治疗铂类药物不耐受可手术的高危尿路上皮癌患者。
Nat Med. 2020 Dec;26(12):1845-1851. doi: 10.1038/s41591-020-1086-y. Epub 2020 Oct 12.
6
Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.新辅助和辅助化疗治疗上尿路尿路上皮癌:2020 年系统评价和荟萃分析,以及系统治疗的未来展望。
Eur Urol. 2021 May;79(5):635-654. doi: 10.1016/j.eururo.2020.07.003. Epub 2020 Aug 12.
7
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2020 年更新版。
Eur Urol. 2021 Jan;79(1):62-79. doi: 10.1016/j.eururo.2020.05.042. Epub 2020 Jun 24.
8
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses.肿瘤微环境:阻碍抗肿瘤免疫反应的环境。
Front Immunol. 2020 May 15;11:940. doi: 10.3389/fimmu.2020.00940. eCollection 2020.
9
Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection.组织硬度导致经尿道膀胱肿瘤切除术患者的 YAP 激活。
Ann N Y Acad Sci. 2020 Aug;1473(1):48-61. doi: 10.1111/nyas.14358. Epub 2020 May 19.
10
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.深度学习从常规组织病理切片预测肌肉浸润性膀胱癌的分子亚型。
Eur Urol. 2020 Aug;78(2):256-264. doi: 10.1016/j.eururo.2020.04.023. Epub 2020 Apr 27.